Contract 75A50120C00177
Vedanta Biosciences, Inc. · Department Of Health And Human Services · September 25, 2020
Vedanta Biosciences, Inc. was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on September 25, 2020 for $79.15 million of work in research and development in biotechnology (except nanobiotechnology). Performance is in Boston, MA. It was awarded under full and open competition. The contract has been modified 16 times since the base award It uses cost sharing contract pricing. The most recent modification was on April 2, 2026.
Contract details
- PIID
- 75A50120C00177
- Award type
- Definitive Contract
- Pricing
- Cost Sharing
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- R&D- Other Research And Development (Advanced Development)
- Place of performance
- Boston, MA
- First action
- September 25, 2020
- Latest action
- April 2, 2026
Description
EO14042 TO DEVELOP MEDICAL COUNTERMEASURES (MCMS) THAT TREAT ANTIBIOTIC RESISTANT INFECTIONS.
Modification timeline
-
April 2, 2026Mod P00016$0
-
December 3, 2025Mod P00015$0
-
September 23, 2025Mod P00014$0
-
May 16, 2025Mod P00013$12.50M
-
February 18, 2025Mod P00012$5.50M
-
July 17, 2024Mod P00011$10.00M
-
April 26, 2024Mod P00010$0
-
February 14, 2024Mod P00009$15.00M
-
April 7, 2023Mod P00008$0
-
February 27, 2023Mod P00007$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | The Boeing Company | 1 | $4.44B |
| 2 | Advanced Technology International | 9 | $3.35B |
| 3 | Amgen USA Inc | 2 | $774.69M |
| 4 | Siga Technologies, Inc. | 1 | $624.44M |
| 5 | Icon Government And Public Health Solutions, Inc. | 16 | $404.80M |
| 6 | Technical Resources International, Inc. | 19 | $395.29M |
| 7 | Allucent Government Services (Us) Llc | 9 | $384.26M |
| 8 | Mapp Biopharmaceutical, Inc. | 7 | $354.24M |
| 9 | Ppd Development Lp | 18 | $331.02M |
| 10 | Albert B. Sabin Vaccine Institute, Inc. (The) | 2 | $305.87M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75A50120C00177?
Contract 75A50120C00177 is a federal contract awarded to Vedanta Biosciences, Inc. by Department Of Health And Human Services on September 25, 2020 for $79.15 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 16 times since the base award.
Who won contract 75A50120C00177?
Vedanta Biosciences, Inc. won contract 75A50120C00177 from Department Of Health And Human Services.
How much is contract 75A50120C00177 worth?
Contract 75A50120C00177 has obligated $79.15 million to date, with a total potential value of $114.15 million if all options are exercised.